A major investment in research by the Ontario government will help OICR and other organizations bring health and economic benefits to the people of the province.
In a press release distributed today, Minister of Colleges and Universities Jill Dunlop announced three years of funding for OICR and four other Ontario-based research organizations: Ontario Genomics, Clinical Trials Ontario, The Fields Institute and Compute Ontario.
This investment will allow OICR to implement our new Strategic Plan and continue to conduct and support world-class translational cancer research that leads to life-changing patient outcomes. It will ensure OICR researchers and collaborators across Ontario can continue their innovative studies, and allow us to offer new funding opportunities that support research and translate findings into healthcare and policy solutions.
The government’s investment in OICR will also fuel our work with our strategic partner, FACIT, to ensure the economic benefits of Ontario’s research innovations stay in Ontario, helping lead Ontario out of the pandemic and into the future.
As part of today’s announcement, OICR President and Scientific Director Dr. Laszlo Radvanyi joined Minister Dunlop and representatives from the other four organizations in a video message.
“With this generous support from the Government of Ontario, OICR will develop new knowledge and tools to fight cancer as effectively as possible, help patients live longer, healthier lives and bring economic benefits to the people of Ontario,” Dr. Radvanyi said.
Read more about today’s announcement from the Government of Ontario.